Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NEOSTIGMINE METHYLSULFATE USP, with a corresponding US DMF Number 33130.
Remarkably, this DMF maintains an Active status since its submission on August 30, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 11, 2018, and payment made on August 29, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II